Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 8Completed 3Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 4354Neoplasms 3055Prostatic Neoplasms 1904Colorectal Neoplasms 1738Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Multiple Myeloma 951Leukemia, Myeloid, Acute 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 740Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

regorafenib 1Cholangiopancreatography, Endoscopic Retrograde 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Bile Duct Diseases × Clear all
NCT04341909 2022-06-07

TIERS

Clinical Hospital Colentina

Completed
1,283 enrolled
Gastrointestinal

Bile Duct Diseases, Pancreatic Neoplasms

NCT02115542 2021-10-12

Single Agent Regorafenib in Refractory Advanced Biliary Cancers

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
39 enrolled 11 charts
Gastrointestinal

Bile Duct Diseases, Bile Duct Neoplasms, Carcinoma, Gallbladder Diseases, Gallbladder Neoplasms, Neoplasm Metastasis

NCT00930410 2013-03-20

EMID

Institut Paoli-Calmettes

Phase NA Completed
50 enrolled
Gastrointestinal

Bile Duct Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡